A cell surface proteomic atlas reveals socioeconomic status associated immune diversity

This study utilizes high-dimensional flow cytometry to map socioeconomic status-associated immune diversity across Senegalese and European cohorts, revealing that lower SES correlates with downregulated surface adhesins and receptors alongside markers of chronic activation, while higher SES is linked to superior protein translation rates.

The Gist

Imagine your immune system as a highly trained, 24/7 security team guarding a massive castle (your body). This team has thousands of different guards: some stand at the gates, some patrol the walls, some are the heavy artillery, and others are the intelligence officers.

For a long time, scientists knew that where you live and how much money you have (your Socioeconomic Status, or SES) affects how well this security team works. But they didn't know exactly what was happening inside the guards' uniforms.

This study is like a massive, high-tech inspection of the security team's uniforms and equipment across two different castles: one in the Netherlands (wealthier, high SES) and one in Senegal (split between wealthier and poorer neighborhoods). The researchers used a super-powerful microscope (spectral flow cytometry) to check 331 different buttons, badges, and tools on 33 different types of guards.

Here is what they found, explained simply:

1. The "Uniforms" of the Poorer Guards Were Worn Out

The most striking discovery was that the guards from the lower-income groups had fewer tools and badges on their uniforms compared to the wealthier groups.

• The Analogy: Imagine two police officers. The one from a wealthy district has a full kit: a radio, a map, a first-aid kit, and a badge that says "I can call for backup." The officer from the poorer district has a radio with no batteries, no map, and a badge that is faded.
• The Science: The poorer guards had lower levels of "adhesins" (glue that helps them stick to invaders) and "chemokine receptors" (GPS systems that tell them where to go). Without these, they are like soldiers trying to fight a battle without a map or a way to hold onto the enemy.

2. The "Burned-Out" Guards

While the poorer guards had fewer tools, they also looked exhausted and overworked.

• The Analogy: These guards were wearing "Do Not Disturb" signs and "I'm Tired" badges. They had too many "stop" signs (immune checkpoints) on their uniforms, which tells them to shut down and stop fighting. They also looked like they had been fighting for years without a break, showing signs of "aging" (senescence).
• The Science: The study found higher levels of markers like CD57 and CD160, which indicate the cells are tired, old, and ready to retire. This is likely because their environment is full of more germs and stress, forcing them to fight constantly until they burn out.

3. The "Factory" Glitch: Writing vs. Building

This is the most fascinating part. The researchers looked at the guards' "instruction manuals" (RNA) and their "construction sites" (Protein production).

• The Analogy: Imagine a factory.
  • High SES Factory: The managers write the blueprints (RNA) and then immediately build the product (Protein) efficiently.
  • Low SES Factory: The managers are writing more blueprints than usual (high RNA), but the construction workers are moving in slow motion. They are writing the instructions but failing to build the actual tools.
• The Science: The poorer individuals had high levels of RNA (the instructions), but their cells were bad at turning those instructions into actual proteins. It's like having a library full of books on how to build a car, but no one actually building the car. This means when a real threat (like a virus or a vaccine) arrives, their immune system is slow to react because they can't build the necessary weapons fast enough.

4. The "Germinal Center" Problem (Vaccine Failure)

One specific group of guards, the B-cells, are responsible for learning how to fight new enemies and creating "memory" (which is how vaccines work).

• The Analogy: To learn a new fight, these guards need to go to a special training camp called the "Germinal Center." The study found that the poorer guards were missing the tickets (receptors like CXCR5 and IL-21R) needed to enter this training camp.
• The Result: Without the tickets, they can't get the advanced training. This explains why vaccines often work less effectively in poorer populations; the immune system literally can't get to the classroom to learn the lesson.

5. The "Complement" Paradox

The study also looked at the "artillery" (complement system). Surprisingly, the wealthy Senegalese group had more active artillery than the poorer group, even though the poorer group had more germs around them.

• The Analogy: It's like a neighborhood where the rich people have a fully stocked armory that is ready to fire, while the poor neighborhood has a broken armory that they are trying to fix, but it's not working. The researchers think the wealthy group's immune system is constantly "on alert" due to subtle environmental triggers, while the poor group's system is too worn out to fire effectively.

The Big Picture

This paper tells us that poverty doesn't just make you hungry; it physically rewires your body's defense system.

It creates a "double whammy" for people with lower socioeconomic status:

1. They lose their tools: They have fewer receptors to find and grab germs.
2. They lose their energy: Their cells are exhausted and can't build new weapons quickly enough when needed.

Why does this matter?
If we understand that a person's immune system is "broken" in specific ways because of their living conditions, doctors can design better vaccines and treatments that don't rely on the body's natural ability to build those tools. Instead of just giving a standard vaccine, we might need to give a "super-charged" one that helps the tired, tool-less guards fight back.

The authors even built a public interactive map (a website) where anyone can look up these "uniform buttons" to see how they differ between groups, helping scientists everywhere understand how social inequality changes our biology.

Technical Summary

1. Problem Statement

Socioeconomic status (SES) is a well-documented determinant of global health disparities and immune system variation. However, the molecular mechanisms linking SES to immune function remain largely unexplored. Previous studies have been limited by:

• Narrow scope: Focusing on specific pathways or a small number of markers rather than a holistic view.
• Lack of high-dimensional data: Few studies have utilized unbiased, high-throughput approaches to map the entire cell surface proteome across diverse immune subsets in relation to SES.
• Geographic bias: A lack of large-scale immune atlases from the Global South (e.g., West Africa), leading to potential inequities in understanding vaccine efficacy and disease outcomes in low-resource settings.

The study aims to create a comprehensive, unbiased atlas of the cell surface proteome to define how SES reshapes the human immune landscape.

2. Methodology

The researchers employed a high-dimensional spectral flow cytometry approach combined with metabolic labeling to profile immune cells from three distinct cohorts:

• Cohorts:
  • European (Netherlands): High SES reference group.
  • Senegalese (West Africa): Stratified into High SES (Dakar city) and Low SES (Rufisque, sub-urban).
  • Participants were healthy adults (18–40 years), matched for age and sex.
• Discovery Phase (LEGENDScreen):
  • Platform: Spectral flow cytometry (Cytek Aurora).
  • Scale: Profiled 331 cell surface proteins across 33 distinct immune cell subsets (including T, B, NK, myeloid, and dendritic cells).
  • Technique: Used the LEGENDScreen™ kit combined with combinatorial sample barcoding (using anti-CD45 and four fluorochromes) to multiplex up to 15 samples per batch, reducing batch effects.
  • Analysis: Applied linear mixed-effects models (limma) to test for monotonic trends across the SES gradient (European > High SES Senegal > Low SES Senegal).
• Validation Phase:
  • An independent cohort ($N=10$ per group) was analyzed using three targeted panels (T cells, Myeloid, B cells) to confirm key findings.
• Functional Assays:
  • Complement Activity: Measured serum C5b-9 deposition via ELISA across classical, lectin, and alternative pathways.
  • Metabolic Profiling: Used bioorthogonal labeling to measure nascent RNA transcription (5'-ethynyl uridine, 5'EU) and protein translation ($\beta$-ethynylserine, $\beta$ES) in resting and stimulated (TLR/TCR/BCR) conditions.
• Data Resources:
  • Developed an interactive Shiny web application for public exploration of the atlas.
  • Data deposited in Zenodo (restricted access).

3. Key Contributions

• First High-Dimensional SES Atlas: Generated the first comprehensive map of >300 surface proteins across 33 immune subsets stratified by SES in both European and West African populations.
• Identification of a Conserved Signature: Defined a specific "SES-associated immune signature" characterized by the downregulation of critical surface proteins in low-SES individuals.
• Uncoupling of Transcription and Translation: Revealed a metabolic disconnect where low-SES individuals exhibit elevated baseline RNA transcription but reduced protein translation efficiency upon activation.
• Interactive Public Resource: Created a freely accessible digital tool (Shiny app) allowing researchers to query marker expression patterns across cell types and SES groups.

4. Key Results

A. Global Proteomic Downregulation in Low SES

• 108 unique surface markers showed significant SES-associated expression patterns.
• 91 markers were associated with Higher SES, while 17 were associated with Lower SES.
• Low SES Phenotype: Characterized by a systemic downregulation of adhesins, chemokine receptors, and complement receptors.
  • Examples: Reduced CCR1 on monocytes, reduced Integrin $\beta$7 on B cells, and reduced C3aR/C5aR on MAIT cells and monocytes.
• High SES Phenotype: Associated with upregulation of receptors involved in migration and germinal center formation (e.g., Notch-2, CD62L).

B. Immune Exhaustion and Chronic Activation

• Low SES individuals displayed hallmarks of chronic immune activation and exhaustion:
  • Upregulation of Checkpoints: Increased CD160 on MAIT cells, CD276 (B7-H3) on monocytes, and trends toward increased CTLA-4 on Tregs.
  • Senescence Markers: Enrichment of terminally differentiated subsets (CD27- CD8+ Temra, CD57+ Tregs) and IgG+ B cells expressing CD95 (Fas).
  • Myeloid Reprogramming: Low SES showed a pro-inflammatory profile (increased LAMP-2/CD107b), whereas High SES showed an "allergy-related" profile (increased Fc$\epsilon$RI$\alpha$).

C. Impairment of Germinal Center Function

• Critical markers for germinal center (GC) formation and vaccine response were downregulated in Low SES B cells:
  • CXCR5 (CD185) and IL-21R (CD360) were significantly lower on naïve (CD27-) B cells in Low SES individuals.
  • This suggests a structural impairment in the ability to form GCs, potentially explaining reduced vaccine immunogenicity in low-income populations.

D. Complement System Uncoupling

• Despite the downregulation of complement receptors (C3aR, C5aR) on immune cells in Low SES Senegalese, serum complement activity (C5b-9 deposition) was paradoxically higher in High SES Senegalese compared to Low SES and Europeans.
• This indicates an "uncoupling" where receptor expression does not correlate with systemic complement activity, possibly due to genetic polymorphisms or subclinical environmental exposures.

E. Metabolic Reprogramming (Transcription-Translation Uncoupling)

• Baseline: Low SES individuals showed elevated RNA transcription (5'EU uptake) in TCR$\gamma\delta$+ T cells, NK cells, and Temra cells.
• Activation: Upon stimulation, Low SES individuals exhibited blunted protein translation ($\beta$ES uptake) compared to High SES individuals.
• Conclusion: Low SES is associated with a state of "transcriptional noise" or stress where mRNA is produced but not efficiently translated into functional proteins, particularly in activated states.

5. Significance and Implications

• Vaccine Efficacy: The downregulation of GC-related markers (CXCR5, IL-21R) and the metabolic uncoupling provide a mechanistic basis for the observed lower vaccine immunogenicity in low-SES populations.
• Disease Outcomes: The enrichment of exhausted and senescent immune subsets in Low SES suggests accelerated immune aging, potentially increasing susceptibility to persistent pathogens (e.g., CMV) and reducing cancer immunosurveillance.
• Therapeutic Targets: The identification of specific surface proteins (e.g., CD160, CD200R) offers potential targets for immune checkpoint modulation or adjuvant selection tailored to SES contexts.
• Global Health Equity: By providing a high-resolution atlas from the Global South, this study addresses a critical data gap, enabling more equitable development of immunotherapies and vaccination strategies.

In summary, the paper establishes that SES is a potent biological determinant that fundamentally rewires the immune system, shifting it toward a state of chronic activation, exhaustion, and metabolic inefficiency, with profound implications for public health and clinical outcomes.